Polaris Oligonucleotides

September 5, 2024

Polaris Oligonucleotides is a Canadian-based biopharma services provider dedicated to advancing oligonucleotides science by leveraging cutting-edge synthetic chemistry. Our service offer spans all types of synthetic oligonucleotides, and we specialize in highly modified or synthetically challenging sequences. We offer a broad inventory of off-the-shelf modifications and can design and produce custom modifications for specialty applications.

Our team of highly skilled chemists and chemical biologists can handle all typical therapeutic oligonucleotide modalities (siRNA, ASO, PMO), as well as post-synthetic functionalization with molecular effectors for a wide range of applications (fluorescent probes and quenchers, affinity capture tags, cell-penetrating peptides), and we adhere to the highest standards of quality.

Keep up to date with the latest news on RNA therapies